<DOC>
	<DOCNO>NCT00313833</DOCNO>
	<brief_summary>This pilot study design evaluate effectiveness tolerability buprenorphine transdermal system versus placebo health outcome elderly resident supervise live environment . The treatment intervention duration 42 day time supplemental analgesic medication ( usual analgesic care ) provide subject addition study drug .</brief_summary>
	<brief_title>Safety Effectiveness Buprenorphine Transdermal System Elderly Subjects With Chronic Pain : Pilot Study .</brief_title>
	<detailed_description>Buprenorphine synthetic opioid analgesic twenty-five year international clinical experience indicate safe effective variety therapeutic situation relief moderate severe pain . Transdermal system may offer advantage currently indicate oral product include ease convenience use , improve compliance , possible reduction patient care , prolong consistent delivery drug .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>reside nursing home , assist living environment , type supervise live situation principal investigator maintain primary responsibility analgesic management resident . chronic pain musculoskeletal origin manage shortacting opioids . take &gt; 90 mg oral morphine sulfate per day ( single day ) &gt; 50 mcg/hr transdermal fentanyl equivalent . activity restrict totally bed rest . cancerrelated pain . Other protocolspecific exclusion/inclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>elderly</keyword>
	<keyword>supervise living</keyword>
	<keyword>opioid</keyword>
	<keyword>transdermal</keyword>
</DOC>